“Breaking down silos and fostering collaboration to help rare disease patients” – The World Orphan Drug Congress convenes top pharmaceutical and biotech companies, public and private funders, patient advocacy groups and many more.
IRDiRC is delighted to confirm the participation of Dr. David Pearce at the WODC USA during the 3 congress days, in the following sessions:
- Keynote: Clinical Trial Readiness
- Presentation: Towards a World Health Assembly Resolution & Global Action Plan on Rare Diseases
- Fireside chat: Engaging emerging markets in orphan drug clinical trials is critical for rare diseases
Full agenda and more information: https://www.terrapinn.com/conference/world-orphan-drug-congress-usa/Agenda.stm